These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6132381)

  • 1. Clones of cytotoxic T lymphocytes reactive to haptenated allogeneic cells: precursor frequency and characteristics as determined by a split-culture approach.
    Good MF; Nossal GJ
    Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1693-7. PubMed ID: 6132381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of true anti-hapten cytotoxic clones in limit dilution microcultures after correction for "anti-self" activity: precursor frequencies, Ly-2 and Thy-1 phenotype, specificity, and statistical methods.
    Good MF; Boyd AW; Nossal GJ
    J Immunol; 1983 May; 130(5):2046-55. PubMed ID: 6187833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allorestricted cytotoxic T cells. Large numbers of allo-H-2Kb-restricted antihapten and antiviral cytotoxic T cell populations clonally develop in vitro from murine splenic precursor T cells.
    Reimann J; Kabelitz D; Heeg K; Wagner H
    J Exp Med; 1985 Aug; 162(2):592-606. PubMed ID: 2991416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant frequency of cytotoxic T lymphocyte precursor cells specific for TNP-modified allogeneic cells in normal lymphocytes.
    Aizawa S
    Cell Immunol; 1986 Nov; 103(1):27-40. PubMed ID: 3492286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the hapten-specific T cell response. I. Preferential induction of hyporesponsiveness to the D-end of the major histocompatibility complex in the hapten-specific cytotoxic T cell response.
    Scott CF; Tsurufuji M; Benacerraf B; Sy MS
    J Immunol; 1983 Nov; 131(5):2184-9. PubMed ID: 6195256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hapten-specific cytotoxic T cell clones undergo somatic variation of their antigen recognition specificity.
    Weltzien HU; Kempkes B; Jankovic DL; Eichmann K
    Eur J Immunol; 1986 Jun; 16(6):631-9. PubMed ID: 2424767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells.
    Weltzien HU; Kempkes B; Studer R; Melchers I; Eichmann K
    Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte responses in allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the self-repertoire of Ia-restricted T cells but not H-2K/D-restricted T cells.
    Bradley SM; Kruisbeek AM; Singer A
    J Exp Med; 1982 Dec; 156(6):1650-64. PubMed ID: 6217271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNP-specific Lyt-2+ cytolytic T cell clones preferentially respond to TNP-conjugated epidermal cells.
    Shimada S; Katz SI
    J Immunol; 1985 Sep; 135(3):1558-63. PubMed ID: 3874901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
    Sihvola M; Hurme M
    J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactive cytotoxic T cells. I. Alloreactive and allorestricted cytotoxic T cells.
    Reimann J; Heeg K; Miller RG; Wagner H
    Eur J Immunol; 1985 Apr; 15(4):387-93. PubMed ID: 2580715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of T-cell-mediated lympholysis by the murine major histocompatibility complex. I. Preferential in vitro responses to trinitrophenyl-modified self K- and D-coded gene products in parental and F1 hybrid mouse strains.
    Levy RB; Shearer GM
    J Exp Med; 1979 Jun; 149(6):1379-92. PubMed ID: 109568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manifestation of allo H-2-restriction specificity by self H-2-restricted T cells.
    Aizawa S; Sado T
    Cell Immunol; 1990 Oct; 130(1):1-10. PubMed ID: 2397498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of T-cell clones specific for trinitrophenyl (TNP)-modified syngeneic spleen cells (TNP-self).
    Arora PK; Hanna EE
    Indian J Exp Biol; 1989 Oct; 27(10):843-8. PubMed ID: 2483952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction fine specificity of long-term, hapten-specific cytotoxic T cell clones: analysis with H-2Kbm-mutant mice and H-2Kb-specific monoclonal antibodies.
    Pircher H; Hämmerling G; Hengartner H
    Eur J Immunol; 1984 Feb; 14(2):144-52. PubMed ID: 6199212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of I region-restricted hapten-specific cytotoxic T lymphocytes.
    Wagner H; Starzinski-Powitz A; Jung H; Röllinghoff M
    J Immunol; 1977 Oct; 119(4):1365-8. PubMed ID: 302282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.